Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896

Watchlist Manager
Zhejiang Shouxiangu Pharmaceutical Co Ltd Logo
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Watchlist
Price: 21.37 CNY -0.6%
Market Cap: 4.2B CNY
Have any thoughts about
Zhejiang Shouxiangu Pharmaceutical Co Ltd?
Write Note

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Other Current Assets
ÂĄ204.5m
CAGR 3-Years
142%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Other Current Assets
ÂĄ2.4m
CAGR 3-Years
-38%
CAGR 5-Years
-24%
CAGR 10-Years
-25%
S
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
Other Current Assets
ÂĄ139m
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Proya Cosmetics Co Ltd
SSE:603605
Other Current Assets
ÂĄ304m
CAGR 3-Years
31%
CAGR 5-Years
34%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Other Current Assets
ÂĄ288.3m
CAGR 3-Years
-45%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Other Current Assets
ÂĄ29.2m
CAGR 3-Years
-48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Consumer products

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Intrinsic Value
33.69 CNY
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Other Current Assets?
Other Current Assets
204.5m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Other Current Assets amounts to 204.5m CNY.

What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
60%

Over the last year, the Other Current Assets growth was 886%. The average annual Other Current Assets growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been 142% over the past three years , 60% over the past five years .

Back to Top